Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,017 shares at $425.70 ($1.7M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($1.7M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $431.79 | 3,309 | $1.4M | 82.6% |
| 2 | $425.70 | 354 | $151K | 8.7% |
| 3 | $425.70 | 354 | $151K | 8.7% |
| Total | $430.72 avg | 4,017 | $1.7M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |